Chinese health care stocks rallied 61 per cent last year with more upside expected in 2021. The pressure, however, will be on drug makers and device manufacturers after massive price cuts.
( read original story …)
Home NEWS Coronavirus in China: 2021 outlook brightens for health care operators, pharmaceutical and device makers after price cuts
ADVERTISEMENT
Categories
Beijing
22°
overcast clouds
humidity: 21%
wind: 1m/s SW
H 22 • L 20
Weather from OpenWeatherMap
Recent Posts
- Report: Russia is giving China ‘incredibly important’ military technology to use against US 13/08/2026
- COVID-19 uptick seen as normal fluctuation 13/08/2026
- Fubon Bank’s Hong Kong subsidiary opens first mainland China branch in Shenzhen 13/08/2026
- Ruanyun Edai Technology Announces Saudi-China Innovation Collaboration with Intersect Holding 13/08/2026
- Rain pounds Beijing as Typhoon Dolphin sweeps through China 13/08/2026
- Beijing shuts tourist sites, suspends bus services as heavy rain continues 13/08/2026
- China’s Sinopec Buys Russian Oil Imports to Offset Middle East Supply Cuts 13/08/2026
- Trade Between U.S. And China Increases 13/08/2026
- ModelBest Begins Pre-IPO Tutoring as On-Device AI Competition Heats Up 13/08/2026
- China responds to expanded UFLPA Entity List, blacklists six US companies 13/08/2026
- China’s most wanted crypto queen vanished – one tiny transfer gave her away 13/08/2026
- Shenzhen, Hong Kong, and the two competing mega-bridges designed to build a 100 million person megalopolis 13/08/2026